Charles M. Farkas

Charles M. Farkas has served as a Director of the Company since July 2014. Mr. Farkas has spent the past 38 years at Bain & Company. He became an Advisory Partner effective July 1, 2015. Prior to this, Mr. Farkas was a Senior Partner at Bain & Company, served as the Global Co-Head of Bain's Healthcare Practice and advised leading medical technology and pharmaceutical companies in the United States, Europe, and Asia. He also advised academic medical centers and provider organizations in the United States. Mr. Farkas has served as the managing director of Bain Canada and as the global leader of Bain & Company's Financial Services practice. Mr. Farkas is also on the Board of Harvard Medical School and the John A. Hartford Foundation and is a Corporator of Partners Healthcare. He is a special advisor to Altamont Capital Partners to support their investments in small-cap healthcare businesses.

The Board of Directors has determined that Mr. Farkas is independent within the meaning of the rules of the Securities and Exchange Commission. Mr. Farkas’ qualifications for election to CONMED’s Board include his almost 40 years working in healthcare in the US and around the world. Mr. Farkas is a highly-respected leader with a strong academic background, and he offers the other directors new strategic and governance perspectives, drawing on his vast experience inside and outside the healthcare industry. Mr. Farkas was initially appointed to the Company’s Board of Directors pursuant to an agreement, now expired, between the Company and Coppersmith Capital Management, LLC (“Coppersmith Capital”) and certain of its affiliates.